85 related articles for article (PubMed ID: 9523516)
1. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon.
Ullman T; Odze R; Farraye FA
Inflamm Bowel Dis; 2009 Apr; 15(4):630-8. PubMed ID: 18942763
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer surveillance in patients with inflammatory bowel disease: What is new?
Guagnozzi D; Lucendo AJ
World J Gastrointest Endosc; 2012 Apr; 4(4):108-16. PubMed ID: 22523611
[TBL] [Abstract][Full Text] [Related]
3. Implementing a Combined Phone and Mail Recall to Increase Screening Colonoscopy Rates in Adults With Chronic Ulcerative Colitis.
Glover G
Gastroenterol Nurs; 2023 Jul-Aug 01; 46(4):275-281. PubMed ID: 37199398
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice.
Ishigamori R; Komiya M; Takasu S; Mutoh M; Imai T; Takahashi M
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28505114
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease associated neoplasia: A surgeon's perspective.
Althumairi AA; Lazarev MG; Gearhart SL
World J Gastroenterol; 2016 Jan; 22(3):961-73. PubMed ID: 26811640
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer.
Eisenach PA; Soeth E; Röder C; Klöppel G; Tepel J; Kalthoff H; Sipos B
Br J Cancer; 2013 Aug; 109(3):694-703. PubMed ID: 23839495
[TBL] [Abstract][Full Text] [Related]
7. Effect of adenovirus-mediated PTEN gene on ulcerative colitis-associated colorectal cancer.
Li Z; Liu GX; Liu YL; Chen X; Huang XL; Gan HT
Int J Colorectal Dis; 2013 Aug; 28(8):1107-15. PubMed ID: 23516074
[TBL] [Abstract][Full Text] [Related]
8. Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
Pagán B; Isidro AA; Cruz ML; Ren Y; Coppola D; Wu J; Appleyard CB
World J Gastroenterol; 2011 Nov; 17(44):4858-66. PubMed ID: 22171126
[TBL] [Abstract][Full Text] [Related]
9. Intestinal cancer risk in Crohn's disease: a meta-analysis.
Laukoetter MG; Mennigen R; Hannig CM; Osada N; Rijcken E; Vowinkel T; Krieglstein CF; Senninger N; Anthoni C; Bruewer M
J Gastrointest Surg; 2011 Apr; 15(4):576-83. PubMed ID: 21152994
[TBL] [Abstract][Full Text] [Related]
10. Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer.
Pagán B; Isidro AA; Coppola D; Chen Z; Ren Y; Wu J; Appleyard CB
Anticancer Res; 2010 Sep; 30(9):3345-53. PubMed ID: 20944107
[TBL] [Abstract][Full Text] [Related]
11. Appendiceal-sigmoid fistula presenting in a man with ulcerative colitis: a case report.
Santangelo M; Lanteri R; D'Angelo M; Carnazzo SA; Ragalbuto A; Minutolo V; Licata A
J Med Case Rep; 2010 Jul; 4():229. PubMed ID: 20667144
[TBL] [Abstract][Full Text] [Related]
12. Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis.
Lichtenstein GR; Deren JJ; Katz S; Lewis JD; Kennedy AR; Ware JH
Dig Dis Sci; 2008 Jan; 53(1):175-80. PubMed ID: 17551835
[TBL] [Abstract][Full Text] [Related]
13. Intestinal cancer in patients with Crohn's disease.
Kersting S; Bruewer M; Laukoetter MG; Rijcken EM; Mennigen R; Buerger H; Senninger N; Krieglstein CF
Int J Colorectal Dis; 2007 Apr; 22(4):411-7. PubMed ID: 16847674
[TBL] [Abstract][Full Text] [Related]
14. Colitic cancer developed after introduction of azathioprine.
Sasaki J; Kawamura YJ; Konishi F; Tosha T
Dig Dis Sci; 2004 Oct; 49(10):1727-9. PubMed ID: 15573934
[No Abstract] [Full Text] [Related]
15. Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor.
Castagliuolo I; Morteau O; Keates AC; Valenick L; Wang CC; Zacks J; Lu B; Gerard NP; Pothoulakis C
Br J Pharmacol; 2002 May; 136(2):271-9. PubMed ID: 12010776
[TBL] [Abstract][Full Text] [Related]
16. p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis.
Walsh S; Murphy M; Silverman M; Odze R; Antonioli D; Goldman H; Loda M
Am J Pathol; 1999 Nov; 155(5):1511-8. PubMed ID: 10550307
[TBL] [Abstract][Full Text] [Related]
17. Cancer and inflammatory bowel disease: bias, epidemiology, surveillance, and treatment.
Solomon MJ; Schnitzler M
World J Surg; 1998 Apr; 22(4):352-8. PubMed ID: 9523516
[TBL] [Abstract][Full Text] [Related]
18. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
